Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up)-Reference-Cited by-同舟云学术

Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up)

Published:2017-05 Issue: Volume:98 Page:54-58
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Leder Benjamin Z.,Tsai Joy N.,Jiang Linda A.,Lee Hang

Funder

NIH

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference30 articles.

1. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research;Adler;J. Bone Miner. Res.,2016

2. Bisphosphonates for osteoporosis—where do we go from here?;Whitaker;N. Engl. J. Med.,2012

3. Continuing bisphosphonate treatment for osteoporosis—for whom and for how long?;Black;N. Engl. J. Med.,2012

4. The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years;Andrews;J. Bone Miner. Res.,2012

5. Postmenopausal osteoporosis;Black;N. Engl. J. Med.,2016

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects;Bone Research;2024-09-05

2. Expert opinion on the management of patients with osteoporosis with anabolic drugs in Italy;Reumatismo;2024-06-24

3. Review of 2022 American College of Rheumatology (ACR) guideline for the prevention and treatment of glucocorticoid-induced osteoporosis: what’s new?;Rheumatology Science and Practice;2024-04-28

4. Bisphosphonates Maintain BMD After Sequential Teriparatide and Denosumab in Premenopausal Women with Idiopathic Osteoporosis;The Journal of Clinical Endocrinology & Metabolism;2024-04-12

5. Sekundäre Frakturprävention/Update Leitlinie Osteoporose 2023 des Dachverbandes Osteologie;Die Unfallchirurgie;2024-03-25